Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6118674 | International Journal of Infectious Diseases | 2013 | 4 Pages |
Abstract
These results indicate that seroprotection following primary vaccination with MenACWY-TT extends more than 3 years. Ongoing persistence data are required to understand the duration of protection following vaccination and to guide decisions on the need for future booster doses.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Lars Ãstergaard, Marie Van der Wielen, Veronique Bianco, Jacqueline M. Miller,